Background. Acute renal dysfunction (ARD) may appear in heart transplant (HTx) patients both in the early
postoperative period and during follow-up, even after several years. CD25 is a subunit of the interleukin-2
receptor which is found exclusively on activated CD4 T lymphocytes. CD25 is crucial for clonal expansion of
anti-allograft host lymphocytes that mediate in acute rejection. There are experiences supporting the use of
Anti-CD25 monoclonal antibodies (MAb) immediately after HTx in patients with ARD as a bridge to renal function
recovery, allowing the temporary suspension of treatment with CNI.
Methods. In this study we report two cases of successful use of weekly MAb (basiliximab) in HTx patients who
developed late ARD after HTx.
Conclusions. In coclusion, we think that in cases of ARD where CNI therapy plays a key role, the use of weekly
doses of basiliximab allows CNI discontinuation until the restoration of renal function is achieved.
Basiliximab, CNI holiday, Heart transplant
Financial support: No grants or funding have been received for this
Pau Alonso La Fe University Hospital Bulevar sur s/n 46008 Valencia Valencia, Spain email@example.com
Share this Article
Related Content In Cardiovascular Disease
ST-elevation Myocardial Infarction and Multivessel Coronary Artery Disease – A Critical Review of Current Practice, Evidence and Meta-analyses
Heart International. 2020;14(2):80-5 DOI: https://doi.org/10.17925/HI.2020.14.2.80
Reperfusion of infarct-related artery (IRA) in acute ST-elevation myocardial infarction (STEMI) is the procedure with the most clinical benefit in interventional cardiology. However, in around 50% of patients presenting with STEMI, other significant lesions are present, a finding which is associated to a worse prognosis.1,2 Most physicians performing primary percutaneous coronary intervention (PCI) have been trained […]
The Role of Transoesophageal Echocardiography in Surgical Removal of a Mediastinal Tumour
Heart International. 2020;14(2):118-20 DOI: https://doi.org/10.17925/HI.2020.14.2.118
Perioperative management of a mediastinal tumour is an anaesthetic challenge. Echocardiography is not considered as a primary diagnostic modality in the evaluation of a mediastinal mass; however, it can provide valuable information in patients with clinical and diagnostic evidence of cardiac compression or encroachment. Judicious interpretation of perioperative transthoracic or transoesophageal echocardiographic images may be […]
Ratio of Serum Aspartate to Alanine Aminotransferase as a Marker of Isolated Coronary Artery Ectasia and its Severity
Heart International. 2020;14(1):43–8 DOI: https://doi.org/10.17925/HI.2020.14.1.43
The exact aetiology of coronary artery ectasia (CAE) has yet to be fully elucidated; however, some underlying aetiologies such as atherosclerosis and microvascular abnormalities in coronary arteries have been proposed.1,2 Over the past few years, several inflammatory markers have been introduced as indicators of CAE and its severity. There is an association between the development of […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!